• menu
    Market Place Market Place
    Sourcing support Sourcing Support
    API / FDF
    Excipients
    Services
    Developments
    News
    Market Intel
    #Phispers
    #SpeakPharma
    #LearnMore

    NEWS

    DRUGS & DEVELOPMENTS

    MARKET INTEL by PharmaCompass

    DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.

    Ryvu Presents RVU120 Data At EHA 2024 Congress

    PR NEWSWIRE

    MorphoSys`s Pelabresib Myelofibrosis Data in ASCO Oral Session

    ACCESSWIRE

    Novartis to acquire cancer-centric MorphoSys for $2.9 bln

    PRESS RELEASE

    MorphoSys’ Pelabresib Improves All Four Hallmarks of Myelofibrosis in Phase 3

    BUSINESSWIRE

    MorphoSys’ Phase 3 Study of Pelabresib in Myelofibrosis Demonstrates Improvement

    BUSINESSWIRE

    Copyright © 2024 LePro PharmaCompass OPC Private Limited, All rights reserved.